Medulloblastoma

8 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Glioma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroectodermal Tumors, Primitive

Treatments and conditions

Medulloblastoma
Treatment and conditionWhere it standsTrials
Educational and Media Intervention for medulloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Eflornithine for medulloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Irradiation + Surgical resection + PEGFILGRASTIM + Vincristine + ETOPOSIDE + TOPOTECAN + Cyclophosphamide + Carboplatin + FILGRASTIM + CISPLATIN + Methotrexate for medulloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Magnetic Resonance Imaging + Laboratory Biomarker Analysis + Radiation Therapy + Vincristine + Lomustine + Cyclophosphamide + CISPLATIN + Vincristine Sulfate for medulloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Metformin hydrochloride for medulloblastomaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ommaya/VPS + Surgical resection + PEGFILGRASTIM + Vincristine + TOPOTECAN + Cyclophosphamide + Carboplatin + FILGRASTIM + CISPLATIN + Methotrexate for medulloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Metformin for medulloblastomaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Surgical resection + PEGFILGRASTIM + Vincristine + TOPOTECAN + Cyclophosphamide + Carboplatin + FILGRASTIM + CISPLATIN + Methotrexate for medulloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.